Cigna Group
For the period ended Sep 30, 2024. Filed Oct 31, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Oct 31, 2024
CI$303.13+2.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Cash Flows
The Cigna Group
Consolidated Statements of Cash Flows
| Unaudited | ||
|---|---|---|
| Nine Months Ended September 30, | ||
| (In millions) | 2024 | 2023 |
| Cash Flows from Operating Activities | ||
| Net income | $2,242 | $4,265 |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||
| Depreciation and amortization | 2,129 | 2,270 |
| Realized investment losses, net | 2,805 | 44 |
| Deferred income tax benefit | (351) | (303) |
| Loss on sale of businesses | 106 | 21 |
| Net changes in assets and liabilities, net of non-operating effects: | ||
| Accounts receivable, net | (10,600) | (1,916) |
| Inventories | 577 | 360 |
| Reinsurance recoverable and Other assets | (358) | 281 |
| Insurance liabilities | (214) | 1,482 |
| Pharmacy and other service costs payable | 8,979 | 2,250 |
| Accounts payable and Accrued expenses and other liabilities | (819) | 1,337 |
| Other, net | 655 | 255 |
| NET CASH PROVIDED BY OPERATING ACTIVITIES | 5,151 | 10,346 |
| Cash Flows from Investing Activities | ||
| Proceeds from investments sold: | ||
| Debt securities and equity securities | 569 | 757 |
| Investment maturities and repayments: | ||
| Debt securities and equity securities | 585 | 715 |
| Commercial mortgage loans | 79 | 86 |
| Other sales, maturities and repayments (primarily short-term and other long-term investments) | 567 | 453 |
| Investments purchased or originated: | ||
| Debt securities and equity securities | (943) | (4,005) |
| Commercial mortgage loans | (54) | (94) |
| Other (primarily short-term and other long-term investments) | (1,028) | (891) |
| Property and equipment purchases, net | (1,069) | (1,208) |
| Acquisitions, net of cash acquired | (132) | (443) |
| Divestitures, net of cash sold | — | 13 |
| Other, net | (485) | (117) |
| NET CASH USED IN INVESTING ACTIVITIES | (1,911) | (4,734) |
| Cash Flows from Financing Activities | ||
| Deposits and interest credited to contractholder deposit funds | 120 | 127 |
| Withdrawals and benefit payments from contractholder deposit funds | (180) | (139) |
| Net change in short-term debt | 366 | 1,484 |
| Repayment of long-term debt | (3,000) | (2,967) |
| Net proceeds on issuance of long-term debt | 4,462 | 1,491 |
| Repurchase of common stock | (5,012) | (1,740) |
| Issuance of common stock | 283 | 113 |
| Common stock dividend paid | (1,183) | (1,092) |
| Other, net | (255) | (321) |
| NET CASH USED IN FINANCING ACTIVITIES | (4,399) | (3,044) |
| Effect of foreign currency rate changes on cash, cash equivalents and restricted cash | 6 | 2 |
| Net (decrease) increase in cash, cash equivalents and restricted cash | (1,153) | 2,570 |
| Cash, cash equivalents and restricted cash January 1, (1) | 8,337 | 5,976 |
| Cash, cash equivalents and restricted cash, September 30, (2) | 7,184 | 8,546 |
| Cash and cash equivalents reclassified to assets of businesses held for sale | (1,249) | — |
| Cash, cash equivalents and restricted cash September 30, per Consolidated Balance Sheets (2) | $5,935 | $8,546 |
| Supplemental Disclosure of Cash Information: | ||
| Income taxes paid, net of refunds | $839 | $1,380 |
| Interest paid | $1,037 | $1,019 |
(1)Includes $467 million reported in Assets of businesses held for sale as of January 1, 2024.
(2)Restricted cash and cash equivalents were reported in other long-term investments.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.